Related Experiment Video
Updated: Jul 18, 2026

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans
Published on: February 4, 2014
Mechanism-based approaches for the reversal of drug neurobehavioral teratogenicity
Joseph Yanai1, Tamar L Ben-Shaanan, Hana Haimovitch
1The Ross Laboratory for Studies in Neural Birth Defects, Department of Anatomy and Cell Biology, The Hebrew University-Hadassah Medical School, Box 12272, 91010 Jerusalem, Israel. yanai@md.huji.ac.il
Abstract:
Understanding the mechanism of neurobehavioral teratogenicity is the primary prerequisite for reversal of the defect. Progress in such studies can be best achieved if the investigation focuses on behaviors related to a specific brain region and innervation. Our model focused on teratogen-induced deficits in hippocampus-related eight-arm and Morris maze behaviors. Different "cholinergic" teratogens, mainly heroin, induced both pre- and postsynaptic hyperactivity in the hippocampal cholinergic innervation that terminated in desensitization of Protein Kinase C (PKC) isoforms to cholinergic receptor stimulation. Understanding this mechanism enabled its reversal with a pharmacological therapy-nicotine infusion. Studies by others provided similar findings by targeting the deficits respective to the model investigated. Consistently, destruction of the A10-septal dopaminergic pathways that downregulate the septohippocampal cholinergic innervation ameliorated maze performance. Grafting of embryonic differentiated cholinergic cells or neural progenitors similarly reversed the biochemical/molecular alterations and the resulting deficits. Reversal therapies offer a model for the understanding of neurobehavioral teratogenicity and, clinically, offer a model for potential treatment of these deficits. Whereas neural progenitor grafting appears to be the most effective treatment, pharmacological reversal with nicotine infusion seems to possess the most feasible and immediate therapy for neurobehavioral birth defects produced by various teratogens, including drugs. This is true even though the effect of pharmacological therapies is diffuse, affecting multiple areas of the brain. "Everybody is talking about the weather but nobody does anything about it." (Mark Twain).
Insights
Neurobehavioral teratogenicity from drugs like heroin can be reversed. Nicotine infusion or neural progenitor grafting can correct hippocampus-related behavioral deficits caused by these toxins.
Area of Science:
- Neuroscience
- Developmental Neuroscience
- Pharmacology
Background:
- Neurobehavioral teratogenicity, resulting from prenatal exposure to toxins, presents significant challenges in understanding and treatment.
- Hippocampus-dependent behaviors are particularly vulnerable to teratogenic insults, impacting cognitive development.
- Identifying specific neurochemical pathways affected by teratogens is crucial for developing targeted interventions.
Purpose of the Study:
- To elucidate the mechanism of neurobehavioral deficits induced by cholinergic teratogens, focusing on hippocampus-related behaviors.
- To investigate the potential for reversing these teratogen-induced deficits using pharmacological and cellular therapies.
- To establish a model for understanding and treating neurobehavioral birth defects.
Main Methods:
- Utilized an animal model to study teratogen-induced deficits in eight-arm and Morris maze tasks, which are hippocampus-dependent.
- Investigated the effects of cholinergic teratogens (e.g., heroin) on hippocampal cholinergic innervation and Protein Kinase C (PKC) signaling.
- Evaluated the efficacy of nicotine infusion and neural progenitor grafting in reversing observed behavioral and molecular alterations.
Main Results:
- Heroin exposure induced pre- and postsynaptic hyperactivity in hippocampal cholinergic innervation, leading to PKC isoform desensitization.
- Nicotine infusion successfully reversed these teratogen-induced deficits and improved maze performance.
- Grafting of embryonic cholinergic cells or neural progenitors also reversed biochemical alterations and behavioral deficits, with progenitor grafting showing higher efficacy.
Conclusions:
- Understanding the specific neurochemical mechanisms of teratogenicity is key to developing effective reversal strategies.
- Pharmacological interventions, such as nicotine infusion, offer a feasible and immediate therapeutic approach for neurobehavioral birth defects.
- Neural progenitor grafting represents a promising, albeit more complex, treatment for reversing teratogen-induced neurodevelopmental abnormalities.
Related Concept Videos
Teratogenicity
Neurochemical Transmission: Sites of Drug Action
Drug Toxicity: Dose-Dependent Reactions
Drugs Affecting Neurotransmitter Synthesis

